Perlecan is a major heparan sulfate proteoglycan of basement membranes
and cell surfaces. Because of its strategic location and ability to s
tore and protect growth factors, perlecan has been implicated in the c
ontrol of tumor cell growth and metastatic behavior. To test the role
of perlecan in malignancy, we generated several stably transfected clo
nes of HT-1080, a human fibrosarcoma cell line, harboring a perlecan c
DNA in the antisense orientation. Surprisingly, clones with a reduced
synthesis of perlecan mRNA and protein core grew faster, formed larger
colonies in semisolid agar, and induced faster formation of s.c. tumo
rs in nude mice than the wild-type cells, Their growth properties in v
itro were independent of exogenous basic fibroblast growth factor, Red
uction of perlecan expression was associated with three distinct prope
rties typical of tumor cells with a more aggressive phenotype: enhance
d migration through 8-mu m-pore filter, increased invasion in Matrigel
-coated filters, and heightened adhesiveness to type IV collagen subst
rata, These results thus provide the first evidence that perlecan may
inhibit the growth and invasiveness of Fibrosarcoma cells in a basic f
ibroblast growth factor-independent pathway and raise the possibility
that perlecan may prevent the infiltration of host tissues in mesenchy
mal neoplasms.